MedPath

Dialysis outcomes in those aged 65 years or over.

Not Applicable
Completed
Conditions
This study is a comprehensive prospective longitudinal survey of health-related quality of life (HRQOL) outcomes, linked to survival, for individuals aged 65 years or over, either on, or eligible for, dialysis therapy.
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12611000024943
Lead Sponsor
niversity of Otago
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
292
Inclusion Criteria

1) Prevalent dialysis patients aged 65 years or over, who have been on dialysis for 90 days prior to survey date will be eligible to participate in the study.
2) Incident (new) chronic kidney disease patients aged 65 years or over, with an eGFR equal to or less than 15 ml/min/1.73m2 presenting to the same services for consideration of dialysis will be eligible to participate in the study. A proportion of these incident patients will decide not to undertake dialysis. They will provide important data to compare and contrast with those who commence dialysis. At present, no data are collected in New Zealand about proportion of patients who decide not to enter a dialysis programme for end stage renal failure, although we estimate this to be 10 of the 40 incident patients recruited to the study each year. 3) Patients aged =65 years who present with hitherto unrecognized renal failure requiring immediate dialysis will be eligible if their renal failure is deemed permanent by the treating nephrologist, and if dialysis is intended to be an indefinite treatment.

Exclusion Criteria

1) Inability to give informed consent, 2) Inability to participate in a telephone or face-to-face interview 3) Intercurrent illness requiring hospitalisation (current and within 2 weeks of the survey period) and of sufficient severity to affect patient’s ability to take part in the opinion of the treating physician (interviews for this last group will be rescheduled for 1 month later).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Short term impact. Quantitative baseline HRQoL and the impact of: age, sex, ethnicity, duration of dialysis and comorbidity on HRQoL from the Cross-Sectional Study. These results will provide a valuable baseline source of data for health workers in this area.[It is expected that the cross-sectional study will be completed, analysed and published before the end of the second year of the project.];Longer term impact. Determination of factors bringing about changes in HRQoL impacting on survival from participants in the Accelerated Longitudinal Study will take a longer time to collate and publish the data. Completion of the data should be towards the end of the 3rd year.[Time points for interviews will be yearly for 3 years to assess longer term impact.]
Secondary Outcome Measures
NameTimeMethod
il[Nil]
© Copyright 2025. All Rights Reserved by MedPath